chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure measurement, Erythema, Flushing, Headache, Heart rate
Clinical narrative: Arm burning from the inside out from injection site right after injection; headache; tingling hand and feet; swelling hands feet and face; swelling face; flushed; red all over wheel down to ED; lump in throat; Low blood pressure; high resting heart rate; This is a spontaneous report from a contactable healthcare professional (patient). A 50-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: e10140), via an unspecified route of administration at the left arm on 11Jan2021 09:15 at single dose for COVID-19 immunization. Medical history included psoriatic arthritis, and allergies to shellfish, sulfa, bees, and, kiwi. The patient was not pregnant at the time of vaccination. Concomitant medication included naproxen sodium (ALEVE) and estradiol (ESTROGEN). The patient previously took naproxen (NAPROSYN) and experienced allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced arm burning from the inside out from injection site right after injection on 11Jan2021 9:15. Seconds later the patient experienced headache, lump in throat, tingling hand and feet, swelling hands, feet, and face, flushed, red all over wheel down to Ed, low blood pressure, and high resting heart rate all on 11Jan2021. The events resulted in emergency room/department or urgent care. Treatment was received for the all the events reported as IV with added therapy. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. The patient had not recovered from the events.; Sender's Comments: Based on the information currently available and due to a plausible temporal relationship, a possible contribution of the suspect product administration to the reported events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heart rate increased, Hypotension, Paraesthesia, Peripheral swelling, Pharyngeal mass
Clinical narrative: Arm burning from the inside out from injection site right after injection; headache; tingling hand and feet; swelling hands feet and face; swelling face; flushed; red all over wheel down to ED; lump in throat; Low blood pressure; high resting heart rate; This is a spontaneous report from a contactable healthcare professional (patient). A 50-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: e10140), via an unspecified route of administration at the left arm on 11Jan2021 09:15 at single dose for COVID-19 immunization. Medical history included psoriatic arthritis, and allergies to shellfish, sulfa, bees, and, kiwi. The patient was not pregnant at the time of vaccination. Concomitant medication included naproxen sodium (ALEVE) and estradiol (ESTROGEN). The patient previously took naproxen (NAPROSYN) and experienced allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced arm burning from the inside out from injection site right after injection on 11Jan2021 9:15. Seconds later the patient experienced headache, lump in throat, tingling hand and feet, swelling hands, feet, and face, flushed, red all over wheel down to Ed, low blood pressure, and high resting heart rate all on 11Jan2021. The events resulted in emergency room/department or urgent care. Treatment was received for the all the events reported as IV with added therapy. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. The patient had not recovered from the events.; Sender's Comments: Based on the information currently available and due to a plausible temporal relationship, a possible contribution of the suspect product administration to the reported events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling face, Vaccination site pain
Clinical narrative: Arm burning from the inside out from injection site right after injection; headache; tingling hand and feet; swelling hands feet and face; swelling face; flushed; red all over wheel down to ED; lump in throat; Low blood pressure; high resting heart rate; This is a spontaneous report from a contactable healthcare professional (patient). A 50-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: e10140), via an unspecified route of administration at the left arm on 11Jan2021 09:15 at single dose for COVID-19 immunization. Medical history included psoriatic arthritis, and allergies to shellfish, sulfa, bees, and, kiwi. The patient was not pregnant at the time of vaccination. Concomitant medication included naproxen sodium (ALEVE) and estradiol (ESTROGEN). The patient previously took naproxen (NAPROSYN) and experienced allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced arm burning from the inside out from injection site right after injection on 11Jan2021 9:15. Seconds later the patient experienced headache, lump in throat, tingling hand and feet, swelling hands, feet, and face, flushed, red all over wheel down to Ed, low blood pressure, and high resting heart rate all on 11Jan2021. The events resulted in emergency room/department or urgent care. Treatment was received for the all the events reported as IV with added therapy. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. The patient had not recovered from the events.; Sender's Comments: Based on the information currently available and due to a plausible temporal relationship, a possible contribution of the suspect product administration to the reported events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dry mouth, Pruritus
Clinical narrative: Started itching of mouth face and upper body within 10 minutes of injection. Became dizzy with tunnel vision. Went to urgent care had elevated blood pressure of 178/110.  Receive steroid injection and prescription for hydroxyzine.
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Dizziness, Oral pruritus, Pruritus, Tunnel vision
Clinical narrative: Started itching of mouth face and upper body within 10 minutes of injection. Became dizzy with tunnel vision. Went to urgent care had elevated blood pressure of 178/110.  Receive steroid injection and prescription for hydroxyzine.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Dyspnoea, Paraesthesia oral, Throat tightness
Clinical narrative: Around 0840 on 2/16/2021 Heart Palpitations, swelling of tongue, left sided neck swelling with diminish flow, tingling of the lips and tongue, pressure, tightness and pain in the chest. shortness of breath, right sided weakness and tingling of limbs and face.  50 ml of Benadryl, and 2 shots of epinephrine was given before transported to the Emergency Room via Ambulance    On 2/22/2021 was sent to Urgent Care with the same symptoms.  Urgent care sent me back to the Emergency room with heart arrythmias, chest tightness, tingling of lips and tongue.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram, Arrhythmia, Chest X-ray, Chest discomfort, Chest pain
Clinical narrative: Around 0840 on 2/16/2021 Heart Palpitations, swelling of tongue, left sided neck swelling with diminish flow, tingling of the lips and tongue, pressure, tightness and pain in the chest. shortness of breath, right sided weakness and tingling of limbs and face.  50 ml of Benadryl, and 2 shots of epinephrine was given before transported to the Emergency Room via Ambulance    On 2/22/2021 was sent to Urgent Care with the same symptoms.  Urgent care sent me back to the Emergency room with heart arrythmias, chest tightness, tingling of lips and tongue.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Electrocardiogram, Hemiparesis, Palpitations, Paraesthesia
Clinical narrative: Around 0840 on 2/16/2021 Heart Palpitations, swelling of tongue, left sided neck swelling with diminish flow, tingling of the lips and tongue, pressure, tightness and pain in the chest. shortness of breath, right sided weakness and tingling of limbs and face.  50 ml of Benadryl, and 2 shots of epinephrine was given before transported to the Emergency Room via Ambulance    On 2/22/2021 was sent to Urgent Care with the same symptoms.  Urgent care sent me back to the Emergency room with heart arrythmias, chest tightness, tingling of lips and tongue.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia oral, Swelling, Swollen tongue
Clinical narrative: Around 0840 on 2/16/2021 Heart Palpitations, swelling of tongue, left sided neck swelling with diminish flow, tingling of the lips and tongue, pressure, tightness and pain in the chest. shortness of breath, right sided weakness and tingling of limbs and face.  50 ml of Benadryl, and 2 shots of epinephrine was given before transported to the Emergency Room via Ambulance    On 2/22/2021 was sent to Urgent Care with the same symptoms.  Urgent care sent me back to the Emergency room with heart arrythmias, chest tightness, tingling of lips and tongue.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blister, Erythema
Clinical narrative: Patient experienced blister-like wound below injection site.  It has since become and open wound with an apparent infection.  The injection site is draining, read, and quite large.  Patient was seen by a physician and- Clinic.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Infection, Injection site infection, Injection site vesicles, Wound
Clinical narrative: Patient experienced blister-like wound below injection site.  It has since become and open wound with an apparent infection.  The injection site is draining, read, and quite large.  Patient was seen by a physician and- Clinic.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Rash
Clinical narrative: 2/16/21 1500 PM received covid vaccine, 2/17/21 at 2200 pm started itching persistently around areas where clothing fit tightly along with a rash. Rash started to spread to bilateral shins appearing as welts. Pt. states that she took claritin and called a nurse. Pt. then took benadryl 25 mg po. Pt. then started taking 50 mg of benadryl for worsening rash and itching.  Pt. states that itching and rash are still present as of 2/23/2021.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pruritus, Rash, Urticaria
Clinical narrative: 2/16/21 1500 PM received covid vaccine, 2/17/21 at 2200 pm started itching persistently around areas where clothing fit tightly along with a rash. Rash started to spread to bilateral shins appearing as welts. Pt. states that she took claritin and called a nurse. Pt. then took benadryl 25 mg po. Pt. then started taking 50 mg of benadryl for worsening rash and itching.  Pt. states that itching and rash are still present as of 2/23/2021.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Rash pruritic
Clinical narrative: 2/16/21 1500 PM received covid vaccine, 2/17/21 at 2200 pm started itching persistently around areas where clothing fit tightly along with a rash. Rash started to spread to bilateral shins appearing as welts. Pt. states that she took claritin and called a nurse. Pt. then took benadryl 25 mg po. Pt. then started taking 50 mg of benadryl for worsening rash and itching.  Pt. states that itching and rash are still present as of 2/23/2021.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Balance disorder, Computerised tomogram head, Delivery, Dizziness, Full blood count normal
Clinical narrative: Red Hives all over body very icitie
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Metabolic function test, Pain in extremity, Urticaria
Clinical narrative: Red Hives all over body very icitie
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: Red Hives all over body very icitie
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Death
Clinical narrative: Patient passed away that night
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Splenomegaly
Clinical narrative: Client stated that her right side  burned and was painful on the evening of 2/16/2021. The pain continued and she went to Hospital on 2/19/2021 , and had an ultrasound. She was not admitted.  She stated that they said her spleen was inflamed. She will go for follow-up at Dr.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Pain, Splenomegaly, Ultrasound scan
Clinical narrative: Client stated that her right side  burned and was painful on the evening of 2/16/2021. The pain continued and she went to Hospital on 2/19/2021 , and had an ultrasound. She was not admitted.  She stated that they said her spleen was inflamed. She will go for follow-up at Dr.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray, Clostridium test positive, Colitis, Computerised tomogram head, Computerised tomogram thorax
Clinical narrative: 1st Vaccine 2/12/21; syncopal episode 2/20/21 ;seen in ED and admitted to hospital same day 2/20/21 Dx:  1. Syncope and collapse  R55 780.2 2. Community acquired pneumonia, unspecified laterality  J18.9 486 3. Acute colitis  K52.9 558.9 4. Leukocytosis, unspecified type  D72.829 288.60 Currently still admitted to hospital at time of this report.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dyspnoea exertional, Leukocytosis, Pneumonia, Syncope
Clinical narrative: 1st Vaccine 2/12/21; syncopal episode 2/20/21 ;seen in ED and admitted to hospital same day 2/20/21 Dx:  1. Syncope and collapse  R55 780.2 2. Community acquired pneumonia, unspecified laterality  J18.9 486 3. Acute colitis  K52.9 558.9 4. Leukocytosis, unspecified type  D72.829 288.60 Currently still admitted to hospital at time of this report.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: White blood cell count increased
Clinical narrative: 1st Vaccine 2/12/21; syncopal episode 2/20/21 ;seen in ED and admitted to hospital same day 2/20/21 Dx:  1. Syncope and collapse  R55 780.2 2. Community acquired pneumonia, unspecified laterality  J18.9 486 3. Acute colitis  K52.9 558.9 4. Leukocytosis, unspecified type  D72.829 288.60 Currently still admitted to hospital at time of this report.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Circulatory collapse, Colitis, Leukocytosis, Pneumonia, Syncope
Clinical narrative: 1st Vaccine 2/12/21; syncopal episode 2/20/21 ;seen in ED and admitted to hospital same day 2/20/21 Dx:  1. Syncope and collapse  R55 780.2 2. Community acquired pneumonia, unspecified laterality  J18.9 486 3. Acute colitis  K52.9 558.9 4. Leukocytosis, unspecified type  D72.829 288.60 Currently still admitted to hospital at time of this report.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Heart rate increased, Hypoaesthesia, Hypoaesthesia oral
Clinical narrative: Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Systemic: Hypertension-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Eye swelling, Hypertension, Mouth swelling, Paraesthesia, Swelling face
Clinical narrative: Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Systemic: Hypertension-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Swollen tongue
Clinical narrative: Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Systemic: Hypertension-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dysphagia, Immediate post-injection reaction, Nausea, Swelling face, Swollen tongue
Clinical narrative: She received her 2nd shot on 2/20/2021.  Within minutes she noticed that she could not see, due to localized swelling around her eyes.  She began to feel itchy and her tongue felt swollen.  She was taken to ED and was given Benadryl and Solu-Medrol, her symptoms continued and she was administered epinephrine about an hour later which immediately cleared up her symptoms.  She has some residual generalized itching and has been taking Benadryl 50 mg every 6 hours until 9:00 p.m. yesterday.  She also takes Zyrtec 10 mg daily starting yesterday.  She denies having any dizziness or lightheadedness, hives urticaria, nasal congestion, weepy eyes, diarrhea or abdominal cramping.  She does endorse nausea and was administered Phenergan in the emergency department.  She also endorses that her eyes felt itchy.  She also endorses that she was able to swallow.   Takes celebrex but paused this prior to the vaccine to prevent possible anti-inflammatory interrupting vaccine efficacy.   Her ED record is available for review.  Exam findings endorse she is tolerating secretions, speaking in full sentences and her tongue was not enlarge. No labs were drawn during her visit.   She denies historical reactions to vaccines. She does get itching with some medications. Historical angioedema/urticaria post pistachio and bran muffin were singular events and have not recurred. She had a normal tryptase in 2014
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Eye pruritus, Nausea, Periorbital swelling, Pruritus, Swollen tongue
Clinical narrative: She received her 2nd shot on 2/20/2021.  Within minutes she noticed that she could not see, due to localized swelling around her eyes.  She began to feel itchy and her tongue felt swollen.  She was taken to ED and was given Benadryl and Solu-Medrol, her symptoms continued and she was administered epinephrine about an hour later which immediately cleared up her symptoms.  She has some residual generalized itching and has been taking Benadryl 50 mg every 6 hours until 9:00 p.m. yesterday.  She also takes Zyrtec 10 mg daily starting yesterday.  She denies having any dizziness or lightheadedness, hives urticaria, nasal congestion, weepy eyes, diarrhea or abdominal cramping.  She does endorse nausea and was administered Phenergan in the emergency department.  She also endorses that her eyes felt itchy.  She also endorses that she was able to swallow.   Takes celebrex but paused this prior to the vaccine to prevent possible anti-inflammatory interrupting vaccine efficacy.   Her ED record is available for review.  Exam findings endorse she is tolerating secretions, speaking in full sentences and her tongue was not enlarge. No labs were drawn during her visit.   She denies historical reactions to vaccines. She does get itching with some medications. Historical angioedema/urticaria post pistachio and bran muffin were singular events and have not recurred. She had a normal tryptase in 2014
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Angioedema, Swollen tongue
Clinical narrative: She received her 2nd shot on 2/20/2021.  Within minutes she noticed that she could not see, due to localized swelling around her eyes.  She began to feel itchy and her tongue felt swollen.  She was taken to ED and was given Benadryl and Solu-Medrol, her symptoms continued and she was administered epinephrine about an hour later which immediately cleared up her symptoms.  She has some residual generalized itching and has been taking Benadryl 50 mg every 6 hours until 9:00 p.m. yesterday.  She also takes Zyrtec 10 mg daily starting yesterday.  She denies having any dizziness or lightheadedness, hives urticaria, nasal congestion, weepy eyes, diarrhea or abdominal cramping.  She does endorse nausea and was administered Phenergan in the emergency department.  She also endorses that her eyes felt itchy.  She also endorses that she was able to swallow.   Takes celebrex but paused this prior to the vaccine to prevent possible anti-inflammatory interrupting vaccine efficacy.   Her ED record is available for review.  Exam findings endorse she is tolerating secretions, speaking in full sentences and her tongue was not enlarge. No labs were drawn during her visit.   She denies historical reactions to vaccines. She does get itching with some medications. Historical angioedema/urticaria post pistachio and bran muffin were singular events and have not recurred. She had a normal tryptase in 2014
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Activated partial thromboplastin time prolonged, Alanine aminotransferase increased, Anaemia, Anion gap, Asthenia
Clinical narrative: The patient was observed at the vaccination site for 15 minutes with no adverse symptoms reported.  The patient presented to the Emergency Department and was admitted for septic shock and pneumonia.   NOTE FROM Chart: Patient is a 38 y o female with PMH of gastric bypass, anemia, DVT in pregnancy, has been on anticoagulation apparently recieved her 2nd dose of COVID 19 vaccine on Friday 02/12/2021 and since saturday has been feeling ill. She developed diffuse blistering in her mouth and was unable to take oral meds. Patient has been taking xarelto but her mother advises that since saturday patient has not taken any meds or food but her mother is not completely sure of the meds. She was brought in to ED with AMS when patient was found on the bathroom floor by family. Patient had difficult to obtain IV access so a central line was placed in ED. Workup revealed patient to be pancytopenic. She also had evidence of Pneumonia and left pleural effusion which seems to be Parapneumonic. Patient has history of sepsis in December 2020.  Patient was noted to be septic. She has allergy to PCN so she was initially started on Avelox for treatment of pneumonia. Patient persistently remained in septic shock despite improvement of lactate levels so Aztreonam was added. Possibility of low blood pressure readings due to anemia and pancytopenia was considered and patient was transfused multiple units of PRBC. Patient developed ARDS / worsening pneumonia despite intervention so antibiotic coverage was changed to Vancomycin and Cefepime was added. Patient was intubated around 2200 due to ARDS and respiratory failure. She has been on pressors and multiple pressors could not keep patients blood pressures up. She was on four pressors and her blood pressures remained extremely low. Patients mother and friend decided to terminally extubate the patient due to extremely poor prognosis despite all interventions. Within minutes patient has died. Her time of death is 5:54 AM.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood albumin decreased, Blood alkaline phosphatase increased, Blood bilirubin increased, Blood creatinine increased, Blood culture positive
Clinical narrative: The patient was observed at the vaccination site for 15 minutes with no adverse symptoms reported.  The patient presented to the Emergency Department and was admitted for septic shock and pneumonia.   NOTE FROM Chart: Patient is a 38 y o female with PMH of gastric bypass, anemia, DVT in pregnancy, has been on anticoagulation apparently recieved her 2nd dose of COVID 19 vaccine on Friday 02/12/2021 and since saturday has been feeling ill. She developed diffuse blistering in her mouth and was unable to take oral meds. Patient has been taking xarelto but her mother advises that since saturday patient has not taken any meds or food but her mother is not completely sure of the meds. She was brought in to ED with AMS when patient was found on the bathroom floor by family. Patient had difficult to obtain IV access so a central line was placed in ED. Workup revealed patient to be pancytopenic. She also had evidence of Pneumonia and left pleural effusion which seems to be Parapneumonic. Patient has history of sepsis in December 2020.  Patient was noted to be septic. She has allergy to PCN so she was initially started on Avelox for treatment of pneumonia. Patient persistently remained in septic shock despite improvement of lactate levels so Aztreonam was added. Possibility of low blood pressure readings due to anemia and pancytopenia was considered and patient was transfused multiple units of PRBC. Patient developed ARDS / worsening pneumonia despite intervention so antibiotic coverage was changed to Vancomycin and Cefepime was added. Patient was intubated around 2200 due to ARDS and respiratory failure. She has been on pressors and multiple pressors could not keep patients blood pressures up. She was on four pressors and her blood pressures remained extremely low. Patients mother and friend decided to terminally extubate the patient due to extremely poor prognosis despite all interventions. Within minutes patient has died. Her time of death is 5:54 AM.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood fibrinogen decreased, Blood lactic acid, Blood magnesium increased, Blood urea increased, Carbon dioxide decreased
Clinical narrative: The patient was observed at the vaccination site for 15 minutes with no adverse symptoms reported.  The patient presented to the Emergency Department and was admitted for septic shock and pneumonia.   NOTE FROM Chart: Patient is a 38 y o female with PMH of gastric bypass, anemia, DVT in pregnancy, has been on anticoagulation apparently recieved her 2nd dose of COVID 19 vaccine on Friday 02/12/2021 and since saturday has been feeling ill. She developed diffuse blistering in her mouth and was unable to take oral meds. Patient has been taking xarelto but her mother advises that since saturday patient has not taken any meds or food but her mother is not completely sure of the meds. She was brought in to ED with AMS when patient was found on the bathroom floor by family. Patient had difficult to obtain IV access so a central line was placed in ED. Workup revealed patient to be pancytopenic. She also had evidence of Pneumonia and left pleural effusion which seems to be Parapneumonic. Patient has history of sepsis in December 2020.  Patient was noted to be septic. She has allergy to PCN so she was initially started on Avelox for treatment of pneumonia. Patient persistently remained in septic shock despite improvement of lactate levels so Aztreonam was added. Possibility of low blood pressure readings due to anemia and pancytopenia was considered and patient was transfused multiple units of PRBC. Patient developed ARDS / worsening pneumonia despite intervention so antibiotic coverage was changed to Vancomycin and Cefepime was added. Patient was intubated around 2200 due to ARDS and respiratory failure. She has been on pressors and multiple pressors could not keep patients blood pressures up. She was on four pressors and her blood pressures remained extremely low. Patients mother and friend decided to terminally extubate the patient due to extremely poor prognosis despite all interventions. Within minutes patient has died. Her time of death is 5:54 AM.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest X-ray abnormal, Culture, Culture urine positive, Death, Escherichia test positive
Clinical narrative: The patient was observed at the vaccination site for 15 minutes with no adverse symptoms reported.  The patient presented to the Emergency Department and was admitted for septic shock and pneumonia.   NOTE FROM Chart: Patient is a 38 y o female with PMH of gastric bypass, anemia, DVT in pregnancy, has been on anticoagulation apparently recieved her 2nd dose of COVID 19 vaccine on Friday 02/12/2021 and since saturday has been feeling ill. She developed diffuse blistering in her mouth and was unable to take oral meds. Patient has been taking xarelto but her mother advises that since saturday patient has not taken any meds or food but her mother is not completely sure of the meds. She was brought in to ED with AMS when patient was found on the bathroom floor by family. Patient had difficult to obtain IV access so a central line was placed in ED. Workup revealed patient to be pancytopenic. She also had evidence of Pneumonia and left pleural effusion which seems to be Parapneumonic. Patient has history of sepsis in December 2020.  Patient was noted to be septic. She has allergy to PCN so she was initially started on Avelox for treatment of pneumonia. Patient persistently remained in septic shock despite improvement of lactate levels so Aztreonam was added. Possibility of low blood pressure readings due to anemia and pancytopenia was considered and patient was transfused multiple units of PRBC. Patient developed ARDS / worsening pneumonia despite intervention so antibiotic coverage was changed to Vancomycin and Cefepime was added. Patient was intubated around 2200 due to ARDS and respiratory failure. She has been on pressors and multiple pressors could not keep patients blood pressures up. She was on four pressors and her blood pressures remained extremely low. Patients mother and friend decided to terminally extubate the patient due to extremely poor prognosis despite all interventions. Within minutes patient has died. Her time of death is 5:54 AM.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Haematocrit decreased, Haemoglobin decreased, Hypotension, International normalised ratio increased, Loss of consciousness
Clinical narrative: The patient was observed at the vaccination site for 15 minutes with no adverse symptoms reported.  The patient presented to the Emergency Department and was admitted for septic shock and pneumonia.   NOTE FROM Chart: Patient is a 38 y o female with PMH of gastric bypass, anemia, DVT in pregnancy, has been on anticoagulation apparently recieved her 2nd dose of COVID 19 vaccine on Friday 02/12/2021 and since saturday has been feeling ill. She developed diffuse blistering in her mouth and was unable to take oral meds. Patient has been taking xarelto but her mother advises that since saturday patient has not taken any meds or food but her mother is not completely sure of the meds. She was brought in to ED with AMS when patient was found on the bathroom floor by family. Patient had difficult to obtain IV access so a central line was placed in ED. Workup revealed patient to be pancytopenic. She also had evidence of Pneumonia and left pleural effusion which seems to be Parapneumonic. Patient has history of sepsis in December 2020.  Patient was noted to be septic. She has allergy to PCN so she was initially started on Avelox for treatment of pneumonia. Patient persistently remained in septic shock despite improvement of lactate levels so Aztreonam was added. Possibility of low blood pressure readings due to anemia and pancytopenia was considered and patient was transfused multiple units of PRBC. Patient developed ARDS / worsening pneumonia despite intervention so antibiotic coverage was changed to Vancomycin and Cefepime was added. Patient was intubated around 2200 due to ARDS and respiratory failure. She has been on pressors and multiple pressors could not keep patients blood pressures up. She was on four pressors and her blood pressures remained extremely low. Patients mother and friend decided to terminally extubate the patient due to extremely poor prognosis despite all interventions. Within minutes patient has died. Her time of death is 5:54 AM.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Mental status changes, Mouth ulceration, Pancytopenia, Platelet count decreased, Pleural effusion
Clinical narrative: The patient was observed at the vaccination site for 15 minutes with no adverse symptoms reported.  The patient presented to the Emergency Department and was admitted for septic shock and pneumonia.   NOTE FROM Chart: Patient is a 38 y o female with PMH of gastric bypass, anemia, DVT in pregnancy, has been on anticoagulation apparently recieved her 2nd dose of COVID 19 vaccine on Friday 02/12/2021 and since saturday has been feeling ill. She developed diffuse blistering in her mouth and was unable to take oral meds. Patient has been taking xarelto but her mother advises that since saturday patient has not taken any meds or food but her mother is not completely sure of the meds. She was brought in to ED with AMS when patient was found on the bathroom floor by family. Patient had difficult to obtain IV access so a central line was placed in ED. Workup revealed patient to be pancytopenic. She also had evidence of Pneumonia and left pleural effusion which seems to be Parapneumonic. Patient has history of sepsis in December 2020.  Patient was noted to be septic. She has allergy to PCN so she was initially started on Avelox for treatment of pneumonia. Patient persistently remained in septic shock despite improvement of lactate levels so Aztreonam was added. Possibility of low blood pressure readings due to anemia and pancytopenia was considered and patient was transfused multiple units of PRBC. Patient developed ARDS / worsening pneumonia despite intervention so antibiotic coverage was changed to Vancomycin and Cefepime was added. Patient was intubated around 2200 due to ARDS and respiratory failure. She has been on pressors and multiple pressors could not keep patients blood pressures up. She was on four pressors and her blood pressures remained extremely low. Patients mother and friend decided to terminally extubate the patient due to extremely poor prognosis despite all interventions. Within minutes patient has died. Her time of death is 5:54 AM.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pneumonia, Prothrombin time prolonged, Rectal haemorrhage, Red blood cell count decreased, Respiratory failure
Clinical narrative: The patient was observed at the vaccination site for 15 minutes with no adverse symptoms reported.  The patient presented to the Emergency Department and was admitted for septic shock and pneumonia.   NOTE FROM Chart: Patient is a 38 y o female with PMH of gastric bypass, anemia, DVT in pregnancy, has been on anticoagulation apparently recieved her 2nd dose of COVID 19 vaccine on Friday 02/12/2021 and since saturday has been feeling ill. She developed diffuse blistering in her mouth and was unable to take oral meds. Patient has been taking xarelto but her mother advises that since saturday patient has not taken any meds or food but her mother is not completely sure of the meds. She was brought in to ED with AMS when patient was found on the bathroom floor by family. Patient had difficult to obtain IV access so a central line was placed in ED. Workup revealed patient to be pancytopenic. She also had evidence of Pneumonia and left pleural effusion which seems to be Parapneumonic. Patient has history of sepsis in December 2020.  Patient was noted to be septic. She has allergy to PCN so she was initially started on Avelox for treatment of pneumonia. Patient persistently remained in septic shock despite improvement of lactate levels so Aztreonam was added. Possibility of low blood pressure readings due to anemia and pancytopenia was considered and patient was transfused multiple units of PRBC. Patient developed ARDS / worsening pneumonia despite intervention so antibiotic coverage was changed to Vancomycin and Cefepime was added. Patient was intubated around 2200 due to ARDS and respiratory failure. She has been on pressors and multiple pressors could not keep patients blood pressures up. She was on four pressors and her blood pressures remained extremely low. Patients mother and friend decided to terminally extubate the patient due to extremely poor prognosis despite all interventions. Within minutes patient has died. Her time of death is 5:54 AM.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test negative, Sepsis, Urinary tract infection, Urine analysis normal, White blood cell count decreased
Clinical narrative: The patient was observed at the vaccination site for 15 minutes with no adverse symptoms reported.  The patient presented to the Emergency Department and was admitted for septic shock and pneumonia.   NOTE FROM Chart: Patient is a 38 y o female with PMH of gastric bypass, anemia, DVT in pregnancy, has been on anticoagulation apparently recieved her 2nd dose of COVID 19 vaccine on Friday 02/12/2021 and since saturday has been feeling ill. She developed diffuse blistering in her mouth and was unable to take oral meds. Patient has been taking xarelto but her mother advises that since saturday patient has not taken any meds or food but her mother is not completely sure of the meds. She was brought in to ED with AMS when patient was found on the bathroom floor by family. Patient had difficult to obtain IV access so a central line was placed in ED. Workup revealed patient to be pancytopenic. She also had evidence of Pneumonia and left pleural effusion which seems to be Parapneumonic. Patient has history of sepsis in December 2020.  Patient was noted to be septic. She has allergy to PCN so she was initially started on Avelox for treatment of pneumonia. Patient persistently remained in septic shock despite improvement of lactate levels so Aztreonam was added. Possibility of low blood pressure readings due to anemia and pancytopenia was considered and patient was transfused multiple units of PRBC. Patient developed ARDS / worsening pneumonia despite intervention so antibiotic coverage was changed to Vancomycin and Cefepime was added. Patient was intubated around 2200 due to ARDS and respiratory failure. She has been on pressors and multiple pressors could not keep patients blood pressures up. She was on four pressors and her blood pressures remained extremely low. Patients mother and friend decided to terminally extubate the patient due to extremely poor prognosis despite all interventions. Within minutes patient has died. Her time of death is 5:54 AM.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory distress syndrome, Autopsy, Death, Endotracheal intubation, Hypotension
Clinical narrative: The patient was observed at the vaccination site for 15 minutes with no adverse symptoms reported.  The patient presented to the Emergency Department and was admitted for septic shock and pneumonia.   NOTE FROM Chart: Patient is a 38 y o female with PMH of gastric bypass, anemia, DVT in pregnancy, has been on anticoagulation apparently recieved her 2nd dose of COVID 19 vaccine on Friday 02/12/2021 and since saturday has been feeling ill. She developed diffuse blistering in her mouth and was unable to take oral meds. Patient has been taking xarelto but her mother advises that since saturday patient has not taken any meds or food but her mother is not completely sure of the meds. She was brought in to ED with AMS when patient was found on the bathroom floor by family. Patient had difficult to obtain IV access so a central line was placed in ED. Workup revealed patient to be pancytopenic. She also had evidence of Pneumonia and left pleural effusion which seems to be Parapneumonic. Patient has history of sepsis in December 2020.  Patient was noted to be septic. She has allergy to PCN so she was initially started on Avelox for treatment of pneumonia. Patient persistently remained in septic shock despite improvement of lactate levels so Aztreonam was added. Possibility of low blood pressure readings due to anemia and pancytopenia was considered and patient was transfused multiple units of PRBC. Patient developed ARDS / worsening pneumonia despite intervention so antibiotic coverage was changed to Vancomycin and Cefepime was added. Patient was intubated around 2200 due to ARDS and respiratory failure. She has been on pressors and multiple pressors could not keep patients blood pressures up. She was on four pressors and her blood pressures remained extremely low. Patients mother and friend decided to terminally extubate the patient due to extremely poor prognosis despite all interventions. Within minutes patient has died. Her time of death is 5:54 AM.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Infectious pleural effusion, Malaise, Mental status changes, Oral mucosal blistering, Packed red blood cell transfusion
Clinical narrative: The patient was observed at the vaccination site for 15 minutes with no adverse symptoms reported.  The patient presented to the Emergency Department and was admitted for septic shock and pneumonia.   NOTE FROM Chart: Patient is a 38 y o female with PMH of gastric bypass, anemia, DVT in pregnancy, has been on anticoagulation apparently recieved her 2nd dose of COVID 19 vaccine on Friday 02/12/2021 and since saturday has been feeling ill. She developed diffuse blistering in her mouth and was unable to take oral meds. Patient has been taking xarelto but her mother advises that since saturday patient has not taken any meds or food but her mother is not completely sure of the meds. She was brought in to ED with AMS when patient was found on the bathroom floor by family. Patient had difficult to obtain IV access so a central line was placed in ED. Workup revealed patient to be pancytopenic. She also had evidence of Pneumonia and left pleural effusion which seems to be Parapneumonic. Patient has history of sepsis in December 2020.  Patient was noted to be septic. She has allergy to PCN so she was initially started on Avelox for treatment of pneumonia. Patient persistently remained in septic shock despite improvement of lactate levels so Aztreonam was added. Possibility of low blood pressure readings due to anemia and pancytopenia was considered and patient was transfused multiple units of PRBC. Patient developed ARDS / worsening pneumonia despite intervention so antibiotic coverage was changed to Vancomycin and Cefepime was added. Patient was intubated around 2200 due to ARDS and respiratory failure. She has been on pressors and multiple pressors could not keep patients blood pressures up. She was on four pressors and her blood pressures remained extremely low. Patients mother and friend decided to terminally extubate the patient due to extremely poor prognosis despite all interventions. Within minutes patient has died. Her time of death is 5:54 AM.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pancytopenia, Pneumonia, Respiratory failure, Septic screen, Septic shock
Clinical narrative: The patient was observed at the vaccination site for 15 minutes with no adverse symptoms reported.  The patient presented to the Emergency Department and was admitted for septic shock and pneumonia.   NOTE FROM Chart: Patient is a 38 y o female with PMH of gastric bypass, anemia, DVT in pregnancy, has been on anticoagulation apparently recieved her 2nd dose of COVID 19 vaccine on Friday 02/12/2021 and since saturday has been feeling ill. She developed diffuse blistering in her mouth and was unable to take oral meds. Patient has been taking xarelto but her mother advises that since saturday patient has not taken any meds or food but her mother is not completely sure of the meds. She was brought in to ED with AMS when patient was found on the bathroom floor by family. Patient had difficult to obtain IV access so a central line was placed in ED. Workup revealed patient to be pancytopenic. She also had evidence of Pneumonia and left pleural effusion which seems to be Parapneumonic. Patient has history of sepsis in December 2020.  Patient was noted to be septic. She has allergy to PCN so she was initially started on Avelox for treatment of pneumonia. Patient persistently remained in septic shock despite improvement of lactate levels so Aztreonam was added. Possibility of low blood pressure readings due to anemia and pancytopenia was considered and patient was transfused multiple units of PRBC. Patient developed ARDS / worsening pneumonia despite intervention so antibiotic coverage was changed to Vancomycin and Cefepime was added. Patient was intubated around 2200 due to ARDS and respiratory failure. She has been on pressors and multiple pressors could not keep patients blood pressures up. She was on four pressors and her blood pressures remained extremely low. Patients mother and friend decided to terminally extubate the patient due to extremely poor prognosis despite all interventions. Within minutes patient has died. Her time of death is 5:54 AM.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Death, Feeding disorder, Fluid intake reduced, Stomatitis
Clinical narrative: The patient was observed at the vaccination site for 15 minutes with no adverse symptoms reported.  The patient presented to the Emergency Department and was admitted for septic shock and pneumonia.   NOTE FROM Chart: Patient is a 38 y o female with PMH of gastric bypass, anemia, DVT in pregnancy, has been on anticoagulation apparently recieved her 2nd dose of COVID 19 vaccine on Friday 02/12/2021 and since saturday has been feeling ill. She developed diffuse blistering in her mouth and was unable to take oral meds. Patient has been taking xarelto but her mother advises that since saturday patient has not taken any meds or food but her mother is not completely sure of the meds. She was brought in to ED with AMS when patient was found on the bathroom floor by family. Patient had difficult to obtain IV access so a central line was placed in ED. Workup revealed patient to be pancytopenic. She also had evidence of Pneumonia and left pleural effusion which seems to be Parapneumonic. Patient has history of sepsis in December 2020.  Patient was noted to be septic. She has allergy to PCN so she was initially started on Avelox for treatment of pneumonia. Patient persistently remained in septic shock despite improvement of lactate levels so Aztreonam was added. Possibility of low blood pressure readings due to anemia and pancytopenia was considered and patient was transfused multiple units of PRBC. Patient developed ARDS / worsening pneumonia despite intervention so antibiotic coverage was changed to Vancomycin and Cefepime was added. Patient was intubated around 2200 due to ARDS and respiratory failure. She has been on pressors and multiple pressors could not keep patients blood pressures up. She was on four pressors and her blood pressures remained extremely low. Patients mother and friend decided to terminally extubate the patient due to extremely poor prognosis despite all interventions. Within minutes patient has died. Her time of death is 5:54 AM.
Age: 92.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Systemic: patient died-Severe, Additional Details: Patient had no adverse effects with the first shot. Patient was monitored the time required after his second dose and had no adverse effects. 90 minutes after administration, patient passed away in his sleep.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure immeasurable, Body temperature increased, Cardio-respiratory arrest, Chills, Death
Clinical narrative: Systemic: Death-Severe, Additional Details: Patient (Resident of facility) received COVID19 2nd dose vaccine at approximately 11am on 2/21. Pharmacy administered the vaccine through the LTC partnership program. Patient had no issues following vaccine. The director of the facility called me on 2.22 to update me on the situation. Per facility, at 8PM patient complained of body aches and chills. At 12AM patient had temperature of 102.2, vomiting, and trouble breathing. Paramedics arrived at 0040. Patient passed away at 0110 at hospital.